MedPath

teleABLE to Reduce Post-Stroke Sedentary Behavior

Not Applicable
Recruiting
Conditions
Stroke
Interventions
Behavioral: teleABLE (telehealth-delivered Activating Behavior for Lasting Engagement)
Other: Health Education
Registration Number
NCT06312709
Lead Sponsor
University of Minnesota
Brief Summary

The goal of this clinical trial to test whether a remotely delivered behavioral activation-based intervention called "teleABLE" works better than a health education intervention for (1) reducing sitting time and (2) improving health-related quality among adults who were diagnosed with stroke within the past 12 months.

Participants in this study will:

* Complete questionnaires at Weeks 1, 8, and 24

* Wear an activPAL monitor at Weeks 1, 8, and 24

* Participate in the teleABLE intervention (12 sessions) or the health education intervention (6 sessions)

* Complete an interview at Week 24

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
92
Inclusion Criteria
  • Age: 18 years or older
  • Diagnosis: Stroke diagnosis ≤12 months prior to study enrollment
  • ≥6 hours of sedentary behavior on a typical weekday (Sedentary Behavior Questionnaire)
  • Able to walk 150 feet or more without physical assistance from another person, with or without assistive device (assessed by Functional Independence Measure, mobility score ≥5)
  • Able to access an electronic device (smartphone, tablet, or computer) that is compatible with a videoconferencing application
  • Able to identify a support person with whom they have a face-to-face interaction at least one time per week.
  • Able and willing to participate fully in the study and provide informed consent
Exclusion Criteria
  • Currently receiving care in an inpatient rehabilitation, transitional care unit, or skilled nursing facility
  • Severe cognitive or communication impairments (inability to respond accurately to complete study telephone screening or complete informed consent)
  • Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma)
  • Comorbid cancer, currently undergoing chemotherapy or radiation treatment
  • Comorbid major depressive disorder (Patient Health Questionnaire-2, score ≥2)
  • Received inpatient treatment or hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
  • Diagnosis of a terminal illness and/or currently receiving hospice care
  • Currently pregnant or expecting to become pregnant in the next 6 months
  • History of skin sensitivity that precludes the use of medical tape necessary for adherence to activity monitor measure
  • Inability to speak, read, or understand English
  • Concurrent participation in any other rehabilitation intervention research study (including cognitive and/or physical rehabilitation studies)
  • Investigator discretion for safety or adherence reasons

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
teleABLEteleABLE (telehealth-delivered Activating Behavior for Lasting Engagement)Participants meet with a study therapist 2x/week for 6 weeks (12 sessions) to complete behavioral activation focused on adding personally meaningful non-sedentary activities during times when they typically spend sitting. All sessions are delivered remotely using Zoom videoconferencing.
Health EducationHealth EducationParticipants meet with a study therapist 1x/week for 6 weeks (6 sessions) to review fact sheets focused on healthy lifestyles after stroke. All sessions are delivered remotely using Zoom videoconferencing.
Primary Outcome Measures
NameTimeMethod
Between-group difference in change in sedentary behaviorWeek 0 to Week 8

Change in mean minutes per day spent in prolonged sedentary time (accumulated in bouts of 30 minutes or more) measured using the activPAL micro4 (7-day wear protocol)

Between-group difference in change scores on health-related quality of lifeWeek 0 to Week 8

European Quality of Life 5-Dimension 5-Level (EuroQOL-5D-5L) change score. The possible range on this tool is -1 (worst) to 1 (best).

Secondary Outcome Measures
NameTimeMethod
Between-group difference in change in sedentary behaviorWeek 0 to Week 24

Change in mean minutes per day spent in prolonged sedentary time (accumulated in bouts of 30 minutes or more) measured using the activPAL micro4 (7-day wear protocol)

Between-group difference in change scores on health-related quality of lifeWeek 0 to Week 24

European Quality of Life 5-Dimension 5-Level (EuroQOL-5D-5L) change score. The possible range on this tool is -1 (worst) to 1 (best).

Trial Locations

Locations (1)

School of Kinesiology, University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath